[Fundamental and clinical evaluation of lividomycin].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000494:pharmacology / Q000627:therapeutic use; D001412:Bacillus subtilis / Q000187:drug effects; D003556:Cystitis / Q000188:drug therapy; D004285:Dogs; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011704:Pyelonephritis / Q000188:drug therapy; D051381:Rats; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary